Unknown

Dataset Information

0

Long-term every-other-day administration of DMAMCL has little effect on aging and age-associated physiological decline in mice.


ABSTRACT: The activation of transcription factor NF-?B is currently identified as one of the driving forces to the aging process. Genetic impairment of NF-?B signaling pathway or pharmacological inhibition of NF-?B activity has been shown to extend healthspan and lifespan in animal models, and delay or reduce many age-related symptoms. However, the aging intervention strategies based on NF-?B inhibition by the suitable small molecular compound is currently still lacking. The water-soluble dimethylaminomicheliolide (DMAMCL), can inhibit NF-?B activity and is currently undergoing clinical trials. In this study, we showed that 15 months of DMAMCL administration started in 1-year old male mice was well-tolerated and safe, and improved or had little effect on some age-associated symptoms, such as neurobehavioral phenotypes, physical performance, cardiac function, hematological parameters, immune aging phenotypes, clinical chemistry parameters, and glucose homeostasis. At the molecular level, DMAMCL administration mitigated serum levels of several age-associated inflammatory cytokines, including IL-6, IL-1?, IL-1?, TNF-?, IFN-?, and CXCL2, and inhibited NF-?B activity in several aged tissues. Collectively, our results indicate that current strategy of DMAMCL administration may has little effect on aging process in mice, and provide basic clues to further exploit the possibility of DMAMCL-based aging intervention to promote healthy aging.

SUBMITTER: Sun Z 

PROVIDER: S-EPMC6535057 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-term every-other-day administration of DMAMCL has little effect on aging and age-associated physiological decline in mice.

Sun Zhaomeng Z   Zhao Lijun L   Su Li L   Fang Qing Q   Xu Chenzhong C   Su Yuanyuan Y   Liang Yao Y   Li Guodong G   Xue Yanxue Y   Tong Tanjun T   Chen Jun J  

Aging 20190501 9


The activation of transcription factor NF-κB is currently identified as one of the driving forces to the aging process. Genetic impairment of NF-κB signaling pathway or pharmacological inhibition of NF-κB activity has been shown to extend healthspan and lifespan in animal models, and delay or reduce many age-related symptoms. However, the aging intervention strategies based on NF-κB inhibition by the suitable small molecular compound is currently still lacking. The water-soluble dimethylaminomic  ...[more]

Similar Datasets

2016-12-01 | GSE85718 | GEO
| S-EPMC5668137 | biostudies-literature
| S-EPMC8134542 | biostudies-literature
| S-EPMC6972906 | biostudies-literature
| S-EPMC6785930 | biostudies-literature
| S-EPMC9893613 | biostudies-literature
| S-EPMC4544717 | biostudies-literature
| S-EPMC6669813 | biostudies-literature
| S-EPMC4531079 | biostudies-other
| S-EPMC3597742 | biostudies-literature